BTS
AGN

BB&T Securities’s Allergan plc AGN Stock Holding History

BB&T Securities’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.82M Sell
22,657
-5,198
-19% -$847K 0.04% 432
2019
Q2 		$4.66M Buy
27,855
+4,872
+21% +$675K 0.04% 403
2019
Q1 		$3.36M Buy
22,983
+6,350
+38% +$921K 0.03% 457
2018
Q4 		$2.22M Sell
16,633
-6,435
-28% -$1.05M 0.02% 519
2018
Q3 		$4.39M Sell
23,068
-2,828
-11% -$520K 0.04% 420
2018
Q2 		$4.32M Sell
25,896
-4,807
-16% -$772K 0.05% 407
2018
Q1 		$5.17M Buy
30,703
+115
+0.4% +$19.3K 0.06% 369
2017
Q4 		$5M Sell
30,588
-8,018
-21% -$1.44M 0.07% 334
2017
Q3 		$7.91M Sell
38,606
-46,917
-55% -$10.9M 0.11% 260
2017
Q2 		$20.8M Buy
85,523
+18,607
+28% +$4.37M 0.3% 79
2017
Q1 		$16M Buy
66,916
+30,660
+85% +$7.14M 0.22% 117
2016
Q4 		$7.98M Buy
36,256
+4,340
+14% +$899K 0.12% 205
2016
Q3 		$7.35M Sell
31,916
-3,478
-10% -$850K 0.11% 215
2016
Q2 		$8.18M Buy
35,394
+19,734
+126% +$4.55M 0.13% 182
2016
Q1 		$4.2M Buy
15,660
+4,858
+45% +$1.39M 0.07% 272
2015
Q4 		$3.38M Sell
10,802
-2,161
-17% -$643K 0.07% 253
2015
Q3 		$3.52M Buy
+12,963
New +$3.98M 0.08% 236
2015
Q2 		– Sell
-14,838
Closed -$4.42M – 1163
2015
Q1 		$4.42M Buy
14,838
+1,292
+10% +$368K 0.1% 185
2014
Q4 		$3.49M Buy
13,546
+2,739
+25% +$685K 0.08% 212
2014
Q3 		$2.61M Buy
10,807
+3,477
+47% +$778K 0.06% 258
2014
Q2 		$1.63M Buy
7,330
+1,872
+34% +$388K 0.04% 338
2014
Q1 		$1.12M Buy
+5,458
New +$1.08M 0.03% 367

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BB&T Securities's AGN Position: Q3 2019 in Review

BB&T Securities reduced its Allergan plc (AGN) stake by 19% in Q3 2019, selling an estimated $847K and leaving 22,657 shares worth $3.82M. The position accounts for 0.04% of the portfolio, ranked #432.

BB&T Securities first reported a position in AGN in Q1 2014 and has held it in 22 quarters since. The position peaked at $20.8M in Q2 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • BB&T Securities held 22,657 shares of Allergan plc worth $3.82M as of Q3 2019.
  • BB&T Securities sold 5,198 Allergan plc shares in Q3 2019, an estimated $847K.
  • Allergan plc made up 0.04% of BB&T Securities's portfolio in Q3 2019, its #432 holding.
  • BB&T Securities first reported a position in Allergan plc in Q1 2014 and has held it in 22 quarters since.
  • BB&T Securities's Allergan plc position peaked at $20.8M in Q2 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.